Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival
暂无分享,去创建一个
Dirk Nagorsen | E. Thiel | H. Stein | C. Loddenkemper | Christoph Loddenkemper | Harald Stein | E. Berg | Eckhard Thiel | Erika Berg | D. Nagorsen | Sabine Voigt | Sabine Voigt
[1] N. Hogg,et al. Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. , 1987, Journal of the National Cancer Institute.
[2] R. Stenling,et al. Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors , 2002, International Journal of Colorectal Disease.
[3] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[4] F. Marincola,et al. Natural T cell immunity against cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] N. Minagawa,et al. Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. , 2003, Anticancer research.
[6] M. De Vos,et al. Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163 , 2004, Annals of the rheumatic diseases.
[7] E. Thiel,et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. , 2000, Cancer research.
[8] F. Marincola,et al. A Genomic- and Proteomic-Based Hypothesis on the Eclectic Effects of Systemic Interleukin-2 Administration in the Context of Melanoma-Specific Immunization , 2004, Cells Tissues Organs.
[9] R. Palmqvist,et al. High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer , 2007, Clinical Cancer Research.
[10] E. Thiel,et al. T cell responses against tumor associated antigens and prognosis in colorectal cancer patients , 2005, Journal of Translational Medicine.
[11] A. Khorana,et al. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma , 2003, Cancer.
[12] H. Ohtani,et al. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis , 2004, British Journal of Cancer.
[13] H. Denk,et al. Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer , 2004, Virchows Archiv.
[14] A. Schned,et al. Dendritic Cell Infiltration in Colon Cancer. , 2001, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[15] R. Steinman,et al. Active immunization against cancer with dendritic cells: The near future , 2001, International journal of cancer.
[16] S. Takeno,et al. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.
[17] E. Thiel,et al. Journal of Translational Medicine in Situ Analysis of Foxp3+ Regulatory T Cells in Human Colorectal Cancer , 2006 .
[18] Frank O. Nestle,et al. Dendritic cells: On the move from bench to bedside , 2001, Nature Medicine.
[19] A. Schned,et al. Dendritic Cell Infiltration in Colon Cancer , 2001, Journal of immunotherapy.
[20] T. Blankenstein. The role of tumor stroma in the interaction between tumor and immune system. , 2005, Current opinion in immunology.
[21] H Nagura,et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.
[22] R. Tollenaar,et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells , 2004, Cancer Immunology, Immunotherapy.
[23] S. H. van der Burg,et al. Prognostic Value of Tumor-Infiltrating Dendritic Cells in Colorectal Cancer: Role of Maturation Status and Intratumoral Localization , 2005, Clinical Cancer Research.
[24] J. Hjelmborg,et al. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells , 2003, Cancer Immunology, Immunotherapy.
[25] Naiem A. Zeid,et al. S 100 Positive Dendritic Cells In Human Lung Tumors Associated With Cell Differentiation And Enhanced Survival , 1993, Pathology.
[26] S. Rutella,et al. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. , 2004, Immunology letters.
[27] V. Kosma,et al. Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.
[28] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[29] M. Furihata,et al. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma— Their distribution in relation to prognosis , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.
[30] M. Mori,et al. S‐100 protein‐positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis , 1989, Cancer.
[31] D. Aust,et al. Characterization of macrophage subpopulations in colon cancer using tissue microarrays , 2005, Histopathology.
[32] I. Nagtegaal,et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study , 2001, BMC Cancer.